CME Group Inc. (CME) vs Marsh & McLennan Companies, Inc. (MRSH)
MRSH leads on 8 of 14 compared metrics.
A side-by-side comparison of CME Group Inc. and Marsh & McLennan Companies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CME
CME Group Inc.
$261.60Financial Services
MRSH
Marsh & McLennan Companies, Inc.
$164.22Financial Services
Total return — CME vs MRSH
growth of $100 · last 24yCME +2949.0%MRSH +248.0%CME compounded faster
Log scale — wide-divergence pair
CME MRSH
CME vs MRSH: by the numbers
- •CME is the larger company ($94.79B vs $79.12B market cap).
- •MRSH trades at the lower earnings multiple (20.53 vs 22.32 P/E).
- •CME converts more revenue to profit (62.77% vs 14.26% net margin).
- •MRSH grew revenue faster over the past five years (9.28% vs 7.93% CAGR).
- •MRSH pays the higher dividend yield (2.19% vs 1.45%).
Which is better, CME or MRSH?
Metric tally: CME 6 · MRSH 8It depends on what you're optimizing for:
ValueMRSH(lower P/E)
GrowthMRSH(faster 5Y revenue CAGR)
IncomeMRSH(higher dividend yield)
QualityMRSH(higher ROIC)
Metrics side by side
Valuation
| Metric | CME | MRSH |
|---|---|---|
| P/E ratio | 22.32 | 20.53● |
| Forward P/E | 20.31 | 15.79● |
| P/S ratio | 14.06 | 2.90● |
| P/B ratio | 3.57● | 5.48 |
| PEG ratio | 1.58● | 7.79 |
Profitability
| Metric | CME | MRSH |
|---|---|---|
| Gross margin | 86.34%● | 42.37% |
| Operating margin | 65.57%● | 21.70% |
| Net margin | 62.77%● | 14.26% |
| ROE | 15.94% | 26.94%● |
| ROIC | 1.62% | 12.12%● |
Dividends
| Metric | CME | MRSH |
|---|---|---|
| Dividend yield | 1.45% | 2.19%● |
| Payout ratio | 33.99% | 42.45% |
Growth (annualized)
| Metric | CME | MRSH |
|---|---|---|
| Revenue CAGR (5Y) | 7.93% | 9.28%● |
| EPS CAGR (5Y) | 13.72% | 16.34%● |
| Total return CAGR (5Y) | 7.56%● | 5.30% |
Frequently asked
- Which is better, CME or MRSH?
- It depends on your goal. value: MRSH (lower P/E); growth: MRSH (faster 5Y revenue CAGR); income: MRSH (higher dividend yield); quality: MRSH (higher ROIC). Across all compared metrics, MRSH leads 8 to 6.
- Is CME or MRSH cheaper?
- On trailing earnings, MRSH is cheaper: CME trades at a 22.32 P/E and MRSH at 20.53.
- Which has grown faster, CME or MRSH?
- Over the past five years, MRSH grew revenue faster — CME at a 7.93% CAGR versus MRSH at 9.28%.
- Does CME or MRSH pay a bigger dividend?
- CME yields 1.45% and MRSH yields 2.19% based on trailing dividends and the latest price.
- Is CME or MRSH more profitable?
- CME runs the higher net margin — CME at 62.77% versus MRSH at 14.26%.
- Which has been the better investment, CME or MRSH?
- Over the past 10-year, CME delivered the higher annualized total return — CME at 14.72% versus MRSH at 11.42%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CME P/E ratioMarsh & McLennan Companies P/E ratioCME dividend yieldMarsh & McLennan Companies dividend yieldCME ROEMarsh & McLennan Companies ROECME operating marginMarsh & McLennan Companies operating marginCME revenue growthMarsh & McLennan Companies revenue growthCME free cash flowMarsh & McLennan Companies free cash flow
CME & Marsh & McLennan Companies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.